Shkrelifreude: while Martin Shkreli rots in prison, his price-gouging pharma company is hemorrhaging money

[Chaz1]

[KathyPartdeux]

@anon30760835

There’s a fair amount of contraband available - and his money will still matter.

Yes, but he has disrespected Wu-Tang Clan. There are doors money does not reopen.

I’m Club Fed - they’d only care if he dissed Martha Stewart. Maybe Perry Como.

[anon30760835]

I’m not as sure that the staff is as melanin deprived as all that though.

On a related note, the Brady Bunch house is for sale again.

[dommerdoodle]

Talk about punchable faces…

[Counterglow]

Well done, sir!

[mcv]

@doctorow

That’s because the population of patients who take Daraprim – the drug Shkreli gouged on – is dwindling, and the remaining patients can’t get their insurers to pay $750/pill.

Is this good news? Do those patients have an affordable alternative?

What we need is a company that response to such extortionate price hikes by introducing a cheap clone of the drug.